Skip to content

Vincenzo Cuomo

4 papers in the library · 675 citations · publishing 2005-2020

Papers

Sort Most recent Most cited

Ketamine administration induces early and persistent neurochemical imbalance and altered NADPH oxidase in mice.

Progress in Neuro-Psychopharmacology and Biological Psychiatry 2020 Stefania Schiavone, M. Morgese, M. Bove et al.

Administration in adulthood of subanaesthetic doses of ketamine, an NMDA receptor (NMDA-R) antagonist, is commonly used to induce psychotic-like alterations in rodents. The NADPH oxidase (NOX) derived-oxidative stress has been shown to be implicated in ketamine-induced neurochemical dysfunctions and in the loss of parvalbumin (PV)-positive interneurons associated to the administration of this...

Propofol enhances memory formation via an interaction with the endocannabinoid system.

Anesthesiology June 1, 2011 Daniela Hauer, Patrizia Ratano, Maria Morena et al.

Propofol is associated with postoperative mood alterations and induces a higher incidence of dreaming compared with other general anesthetics. These effects might be mediated by propofol's inhibitory action on fatty acid amide hydrolase, the enzyme that degrades the endocannabinoid anandamide. Because propofol is also associated with a higher incidence of traumatic memories from perioperative...

The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses

Journal of Neuroscience August 25, 2010 Silvia Sorce, Stefania Schiavone, Paolo Tucci et al.

Subanesthetic doses of NMDA receptor antagonist ketamine induce schizophrenia-like symptoms in humans and behavioral changes in rodents. Subchronic administration of ketamine leads to loss of parvalbumin-positive interneurons through reactive oxygen species (ROS), generated by the NADPH oxidase NOX2. However, ketamine induces very rapid alterations, in both mice and humans. Thus, we have...

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

Proceedings of the National Academy of Sciences December 13, 2005 Gabriella Gobbi, Francis Rodriguez Bambico, Regina A. Mangieri et al. 675 citations

Although anecdotal reports suggest that cannabis may be used to alleviate symptoms of depression, the psychotropic effects and abuse liability of this drug prevent its therapeutic application. The active constituent of cannabis, delta9-tetrahydrocannabinol, acts by binding to brain CB1 cannabinoid receptors, but an alternative approach might be to develop agents that amplify the actions of...

DOI: 10.1073/pnas.0509591102 (opens in new tab) Anandamide Endocannabinoid system Pharmacology Cannabinoid receptor +5